Advanced in Childhood Acute Myeloid Leukemia

Dr. Richard P. Mansour

Hematology Oncology | Hematology | Oncology
Lsu Health Sciences Center Shreveport Faculty Group Practice
1541 Kings Hwy, 
Shreveport, LA 
Accepting New Patients
Advanced in Childhood Acute Myeloid Leukemia
Lsu Health Sciences Center Shreveport Faculty Group Practice
1541 Kings Hwy, 
Shreveport, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Richard Mansour is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Mansour and is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Sickle Cell Disease, Hemoglobin SC Disease, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Mansour is currently accepting new patients.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in LA
Hospital Affiliations
Ochsner Lsu Health Shreveport
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CHRISTUS Health Plan

Accepted plan types not found. Please verify directly with the provider.

Cigna
  • EPO
  • HMO
  • PPO
Clear Spring Health

Accepted plan types not found. Please verify directly with the provider.

CVS Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid

Accepted plan types not found. Please verify directly with the provider.

Medicaid

Accepted plan types not found. Please verify directly with the provider.

Medicare

Accepted plan types not found. Please verify directly with the provider.

Meridian Choice

Accepted plan types not found. Please verify directly with the provider.

Molina

Accepted plan types not found. Please verify directly with the provider.

Mutual of Omaha

Accepted plan types not found. Please verify directly with the provider.

Primewell Health Services

Accepted plan types not found. Please verify directly with the provider.

Silverscript

Accepted plan types not found. Please verify directly with the provider.

Superior Health Plan

Accepted plan types not found. Please verify directly with the provider.

UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
WellCare Health Plans

Accepted plan types not found. Please verify directly with the provider.

View 17 Less Insurance Carriers -

Locations

LSU HEALTH SCIENCES CENTER SHREVEPORT FACULTY GROUP PRACTICE
1541 Kings Hwy, Shreveport, LA 71103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
Enrollment Status: Completed
Publish Date: April 13, 2025
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 2
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: March 21, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Lenalidomide, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: November 29, 2024
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Crizanlizuamb
Study Phase: Phase 2
View 3 Less Clinical Trials

18 Total Publications

Next-Generation Sequencing-Guided Treatment of BRCA2-Mutant Metastatic Uterine Leiomyosarcoma With Poly(ADP-ribose) Polymerase Inhibitor Therapy.
Next-Generation Sequencing-Guided Treatment of BRCA2-Mutant Metastatic Uterine Leiomyosarcoma With Poly(ADP-ribose) Polymerase Inhibitor Therapy.
Journal: JCO precision oncology
Published: December 12, 2024
Similar Doctors
Advanced in Childhood Acute Myeloid Leukemia
Dr. Maxwell C. Mcdonald
Hematology Oncology | Hematology | Oncology
Advanced in Childhood Acute Myeloid Leukemia
Dr. Maxwell C. Mcdonald
Hematology Oncology | Hematology | Oncology

Wk Hematology Oncology Associates

2600 Kings Hwy, Suite 340, 
Shreveport, LA 
 (1.0 mi)
318-212-8620
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Maxwell Mcdonald is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Mcdonald and is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor. Dr. Mcdonald is currently accepting new patients.

Advanced in Childhood Acute Myeloid Leukemia
Dr. Samip R. Master
Hematology Oncology | Hematology | Oncology
Advanced in Childhood Acute Myeloid Leukemia
Dr. Samip R. Master
Hematology Oncology | Hematology | Oncology

Wk Hematology Oncology Associates

2600 Kings Hwy, Suite 340, 
Shreveport, LA 
 (1.0 mi)
318-212-8620
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Samip Master is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Master and is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Sickle Cell Disease, Acute Myeloid Leukemia (AML), Paget Disease of the Breast, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Master is currently accepting new patients.

Experienced in Childhood Acute Myeloid Leukemia
Dr. Poornima Ramadas
Hematology Oncology | Hematology | Oncology
Experienced in Childhood Acute Myeloid Leukemia
Dr. Poornima Ramadas
Hematology Oncology | Hematology | Oncology

Lsu Health Sciences Center Shreveport Faculty Group Practice

1541 Kings Hwy, 
Shreveport, LA 
 (0.1 mi)
318-675-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Poornima Ramadas is a Hematologist Oncology specialist and a Hematologist in Shreveport, Louisiana. Dr. Ramadas and is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Their top areas of expertise are Sickle Cell Disease, Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Ramadas is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mansour's expertise for a condition
ConditionClose
    View All 30 Advanced Conditions
    View All 130 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile